JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Photooxidation of the antidepressant drug Fluoxetine (Prozac®) in aqueous media by hybrid catalytic/ozonation processes.

Water Research 2011 April
This article examines the oxidative disposal of Prozac(®) (also known as Fluoxetine, FXT) through several oxidative processes with and without UV irradiation: for example, TiO(2) alone, O(3) alone, and the hybrid methods comprised of O(3) + H(2)O(2) (PEROXONE process), TiO(2) + O(3) and TiO(2) + O(3) + H(2)O(2) at the laboratory scale. Results show a strong pH dependence of the adsorption of FXT on TiO(2) and the crucial role of adsorption in the whole degradation process. Photolysis of FXT is remarkable only under alkaline pH. The heterogeneous photoassisted process removes 0.11 mM FXT (initial concentration) within ca. 60 min with a concomitant 50% mineralization at pH 11 (TiO(2) loading, 0.050 g L(-1)). The presence of H(2)O(2) enhances the mineralization further to >70%. UV/ozonation leads to the elimination of FXT to a greater extent than does UV/TiO(2): i.e., 100% elimination of FXT is achieved by UV/O(3) in the first 10 min of reaction and almost 97% mineralization is attained under UV irradiation in the presence of H(2)O(2). The hybrid configuration UV + TiO(2) + O(3) + H(2)O(2) enhances removal of dissolved organic carbon (DOC) in ca. 30 min leaving, however, an important inorganic carbon (IC) content. In all cases, the presence of H(2)O(2) improves the elimination of DOC, but not without a detrimental effect on the biodegradability of FXT owing to the low organic carbon content in the final treated effluent, together with significant levels of inorganic byproducts remaining. The photoassisted TiO(2)/O(3) hybrid method may prove to be an efficient combination to enhance wastewater treatment of recalcitrant drug pollutants in aquatic environments.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app